Thursday, December 3, 2015
Parexel International, a global biopharmaceutical services provider, has introduced IMPACT Express Clinical Trial Management System (CTMS). IMPACT Express provides a quick-to-implement, cost-effective clinical trial management solution to simplify clinical trial management and monitoring for small to mid-sized biopharmaceutical companies.
Medidata, a global provider of cloud-based solutions for clinical research in life sciences, and C&R Research, a South Korean full-service CRO, have announced that the Medidata Clinical Cloud platform has been adopted to improve operational efficiencies, resource savings and decision-making processes across C&R’s entire R&D portfolio in Asia.
GHO Capital, a European specialist healthcare investor, has acquired Quotient Clinical, a Nottingham, U.K.-based provider of outsourced, early-stage drug development services to the pharmaceutical industry. Employing more than 280 professionals, Quotient Clinical enables pharmaceutical and biotechnology customers to improve R&D productivity and accelerate drug development timelines.
Thermo Fisher Scientific has opened a new state-of-the-art GMP facility in Singapore. The company, which established its first clinical services facility there in 2001, said the move to the newly built facility will meet the growing demand for clinical supply services in the region. The new site will provide both regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies—from GMP storage, local labeling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies to returns management.
Thermo Fisher Scientific has entered into a long-term agreement with Novartis and Pfizer to develop and commercialize a multi-marker, universal next-generation sequencing (NGS) oncology test that will serve as a companion diagnostic (CDx) for non-small cell lung cancer (NSCLC) across multiple drug development programs.